SMi Reports: Renowned industry experts to present on Disruptive Technologies in Pharma conference taking place in January 2020.
Industry case studies will reveal personal experiences and strategies to approaching digitalisation, providing a benchmark for practice and improving understanding of forecasts until 2020.
Other featured speakers include:
� Joseph Dalton, Global Lead Digital Health Solutions and Medical Outcomes, Novartis on "What is driving the Digital Transformation of the Pharma Industry?"
� Dr Andrew Bate, Senior Director, Analytics Team Lead, Pfizer on "AI-driven Utilisation of Real-World Evidence for R&D"
� Jessica Shull, European Lead, Digital Therapeutics Alliance on "What is required for a DTx product to be successful?"
� Bhushan Bonde, Head of IT - Early Solution Innovation Development, UCB on "Enabling AI Driven Drug Discovery with Cutting Edge �Disruptive� Platform"
� Mark Campbell, Freelance regulatory expert, former NICE on "International Insight into Standards for Seamless Adoption of Prescription Digital Therapeutics"
� Vladimir Anisimov, Principal Data Scientist, Amgen on "Innovative AI technologies for Predicting Patient Enrolment and Optimal Forecasting of Clinical Trial�s Operation"
Highlights of the event:
� Novartis discusses the digital transformation approach utilising artificial intelligence, virtual reality and analyses the forces driving the convergence of PharmaTec
� Pfizer explores AI-enabled real-world evidence platforms for structured data collection and analysis
� Insight into the potential of Digital Therapeutics to enhance patient centricity in pharma
� International insight from former NICE about the regulatory standards surrounding emerging technologies, with special focus on overcoming challenges of implementation
View the full agenda and speaker line-up online at www.disruptivetech-pharma.com/PRcom
Disruptive Technologies in Pharma
20th � 21st January 2020
London, UK
www.disruptivetech-pharma.com/PRcom